Inhibiting fusion with cellular membrane system: therapeutic options to prevent severe acute respiratory syndrome coronavirus-2 infection.

American Journal of Physiology. Cell Physiology
Prasenjit Mitra

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV), an enveloped virus with a positive-sense single-stranded RNA genome, facilitates the host cell entry through intricate interactions with proteins and lipids of the cell membrane. The detailed molecular mechanism involves binding to the host cell receptor and fusion at the plasma membrane or after being trafficked to late endosomes under favorable environmental conditions. A crucial event in the process is the proteolytic cleavage of the viral spike protein by the host's endogenous proteases that releases the fusion peptide enabling fusion with the host cellular membrane system. The present review details the mechanism of viral fusion with the host and highlights the therapeutic options that prevent SARS-CoV-2 entry in humans.

References

Feb 1, 1993·American Journal of Respiratory Cell and Molecular Biology·J M SallenaveA P Ryle
Jun 1, 1997·The Journal of Peptide Research : Official Journal of the American Peptide Society·A BasakG A Lajoie
Feb 5, 1997·Chemical Reviews·Hans-Hartwig Otto, Tanja Schirmeister
Mar 5, 2004·Pharmacotherapy·Hélène Hardy, Paul R Skolnik
Jul 14, 2004·The Journal of Cell Biology·Prasenjit MitraAlonzo H Ross
Dec 13, 2005·The Journal of Biological Chemistry·I-Chueh HuangHyeryun Choe
Feb 10, 2006·Journal of Cell Science·Karine Lindmo, Harald Stenmark
Mar 4, 2008·American Journal of Respiratory Cell and Molecular Biology·Konrad StadlerAldo Baritussio
Dec 17, 2008·Journal of Perinatology : Official Journal of the California Perinatal Association·D J Askew, G A Silverman
Nov 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kailang WuFang Li
Jan 28, 2012·Biochimica Et Biophysica Acta·Peter Mayinger
May 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Quentin McAfeeRavi K Amaravadi
Oct 20, 2014·Nature Chemical Biology·Baptiste RonanBenoit Pasquier
Jan 8, 2015·Expert Opinion on Therapeutic Patents·Frédéric CoutureRobert Day
Feb 11, 2015·Antiviral Research·Yanchen ZhouGraham Simmons
Jan 24, 2016·Journal of Biomedical Science·Yvonne Ting-Chun YuMing-Fu Chang
Nov 3, 2014·Annual Review of Virology·Margaret Kielian
Sep 1, 2016·Annual Review of Virology·Fang Li
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jung-Eun ParkTom Gallagher
Nov 12, 2016·Nature Reviews. Drug Discovery·Yasuko OnoHiroyuki Sorimachi
Jun 5, 2019·Nature Reviews. Drug Discovery·Elie Dolgin
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Feb 13, 2020·Cellular & Molecular Immunology·Shuai XiaLu Lu

❮ Previous
Next ❯

Citations

Feb 13, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ramandeep SinghZhou Xing
Jun 22, 2021·Biochimie·Stéphane OrlowskiEric Bruckert
Aug 9, 2021·Current Opinion in Virology·Christian S StevensBenhur Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

© 2021 Meta ULC. All rights reserved